Search research articles
Contact Us
Filters
Showing results (11-20 of 25) with videos related to
Page
of 3
Sort By:
Neurobiology of Aging
|
May 1, 1996
APOE alleles in Alzheimer's disease and vascular dementia in a population aged 85+
R Sulkava, K Kainulainen, A Verkkoniemi, et al.
Clinical Genetics
|
July 14, 2016
Muscle hypertrophy as the presenting sign in a patient with a complete FHL1 deletion
T A Willis, C L Wood, J Hudson, et al.
Journal of Internal Medicine
|
February 8, 2018
CAIDE Dementia Risk Score, Alzheimer and cerebrovascular pathology: a population-based autopsy study
B Hooshmand, T Polvikoski, M Kivipelto, et al.
The New England Journal of Medicine
|
November 9, 1995
Apolipoprotein E, dementia, and cortical deposition of beta-amyloid protein
T Polvikoski, R Sulkava, M Haltia, et al.
Neurology. Genetics
|
November 11, 2016
Novel <i>HSPB1</i> mutation causes both motor neuronopathy and distal myopathy
D J Lewis-Smith, J Duff, A Pyle, et al.
Neuropathology and Applied Neurobiology
|
November 12, 2005
Cerebral amyloid angiopathy in a 95+ cohort: complement activation and apolipoprotein E (ApoE) genotype
M Tanskanen, P J Lindsberg, P J Tienari, et al.
Neuroscience Letters
|
October 6, 2000
Cardiovascular risk factors and Alzheimer's disease: a genetic association study in a population aged 85 or over
L Myllykangas, T Polvikoski, R Sulkava, et al.
International Psychogeriatrics
|
May 11, 2002
Does apolipoprotein E influence learning and memory in the nondemented oldest old?
A Salo, R Ylikoski, A Verkkoniemi, et al.
Neurology
|
June 27, 2001
Prevalence of Alzheimer's disease in very elderly people: a prospective neuropathological study
T Polvikoski, R Sulkava, L Myllykangas, et al.
Annals of Medicine
|
October 30, 2001
Association of lipoprotein lipase Ser447Ter polymorphism with brain infarction: a population-based neuropathological study
L Myllykangas, T Polvikoski, R Sulkava, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 25) with videos related to
Sort By:
Page
of 3
Neurobiology of Aging
|
May 1, 1996
APOE alleles in Alzheimer's disease and vascular dementia in a population aged 85+
R Sulkava, K Kainulainen, A Verkkoniemi, et al.
Clinical Genetics
|
July 14, 2016
Muscle hypertrophy as the presenting sign in a patient with a complete FHL1 deletion
T A Willis, C L Wood, J Hudson, et al.
Journal of Internal Medicine
|
February 8, 2018
CAIDE Dementia Risk Score, Alzheimer and cerebrovascular pathology: a population-based autopsy study
B Hooshmand, T Polvikoski, M Kivipelto, et al.
The New England Journal of Medicine
|
November 9, 1995
Apolipoprotein E, dementia, and cortical deposition of beta-amyloid protein
T Polvikoski, R Sulkava, M Haltia, et al.
Neurology. Genetics
|
November 11, 2016
Novel <i>HSPB1</i> mutation causes both motor neuronopathy and distal myopathy
D J Lewis-Smith, J Duff, A Pyle, et al.
Neuropathology and Applied Neurobiology
|
November 12, 2005
Cerebral amyloid angiopathy in a 95+ cohort: complement activation and apolipoprotein E (ApoE) genotype
M Tanskanen, P J Lindsberg, P J Tienari, et al.
Neuroscience Letters
|
October 6, 2000
Cardiovascular risk factors and Alzheimer's disease: a genetic association study in a population aged 85 or over
L Myllykangas, T Polvikoski, R Sulkava, et al.
International Psychogeriatrics
|
May 11, 2002
Does apolipoprotein E influence learning and memory in the nondemented oldest old?
A Salo, R Ylikoski, A Verkkoniemi, et al.
Neurology
|
June 27, 2001
Prevalence of Alzheimer's disease in very elderly people: a prospective neuropathological study
T Polvikoski, R Sulkava, L Myllykangas, et al.
Annals of Medicine
|
October 30, 2001
Association of lipoprotein lipase Ser447Ter polymorphism with brain infarction: a population-based neuropathological study
L Myllykangas, T Polvikoski, R Sulkava, et al.
Page
of 3